8-KFinancial EventsOther EventsExhibits & Filings

METLIFE INC 8-K Report, Financial Obligation (Jan 6, 2023)

Filed January 6, 2023For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife Inc. (MET) has filed an 8-K report detailing the issuance of $1 billion in Senior Notes due in 2054. This significant debt offering, carrying a coupon rate of 5.250%, was made under a shelf registration statement and a related prospectus supplement, indicating the company's strategic use of capital markets to fund its operations or strategic initiatives. The issuance was facilitated through underwriting and pricing agreements with several prominent financial institutions, including BofA Securities, Deutsche Bank Securities, HSBC Securities, J.P. Morgan Securities, and Morgan Stanley & Co. The filing also includes supporting legal documentation, such as the supplemental indenture and an opinion letter from Willkie Farr & Gallagher LLP, confirming the validity of these new Senior Notes. Investors should note this as a material event impacting the company's debt structure and leverage.

Key Highlights

  • 1MetLife Inc. issued $1 billion in 5.250% Senior Notes due 2054 on January 6, 2023.
  • 2The notes were issued under a shelf registration statement filed on November 17, 2022, and a prospectus supplement dated January 3, 2023.
  • 3The issuance was conducted through underwriting and pricing agreements with a syndicate of major investment banks.
  • 4This debt issuance increases MetLife's outstanding debt and will impact its leverage ratios.
  • 5The filing includes legal documentation confirming the validity and terms of the Senior Notes.
  • 6The Senior Notes represent a long-term financing commitment for MetLife, with a maturity of 31 years.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report the material event of MetLife Inc. issuing $1 billion in Senior Notes due 2054. This is a significant debt financing transaction that investors need to be aware of.

The Senior Notes have an aggregate principal amount of $1 billion, a fixed coupon rate of 5.250%, and a maturity date in 2054. They were issued under the company's existing senior indenture, as supplemented by a Thirty-Seventh Supplemental Indenture.

This issuance increases MetLife's total debt and will affect its financial leverage ratios. While the exact use of proceeds is not detailed in this specific filing, such debt issuances are typically used for general corporate purposes, refinancing existing debt, or funding strategic initiatives.

The underwriters for this offering included BofA Securities, Inc., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, acting as representatives of the several underwriters.